Management of the health crisis, Covid-19

Panpharma, a pharmaceutical company, manufactures a wide range of injectable medicinal products of Major Therapeutic Interest that are vital to the hospital care of many patients, both generally and for the treatment of opportunistic respiratory and cardiac diseases related to Covid-19. Cognisant and proud of this responsibility, the Panpharma teams, further to government instructions, have reorganised themselves in order to keep critical activities going across all sites. While eligible employees are now working from home, most are physically travelling to the manufacturing sites every day to guarantee the continuity of pharmaceutical manufacture, quality control and distribution activities, in strict compliance with safety measures.

The message addressed at the end of last week by Bruno Le Maire, the Minister of Economy and Finance, and Olivier Véran, the Minister of Health in France, highlights the importance of the pharmaceutical industry’s involvement, a vital link in the medicines supply chain: “On behalf of the French Government, we wish to convey our gratitude and encouragement. Thanks to your courage and your sense of duty, we are in a position to assure that we will overcome this crisis.”

We are proud to be playing a vital and indispensable role in the life of the countries where we operate and to contribute to the management of this unprecedented health crisis.